HomeEli Lilly

Eli Lilly

Why Big Pharma is Betting on Telehealth Strategies

Why Big Pharma is Betting on Telehealth Strategies

September 6, 2024

Evaluating Eli Lilly: A Deep Dive into the Biotech Stock’s Prospects

Evaluating Eli Lilly: A Deep Dive into the Biotech Stock’s Prospects

January 5, 2024

Eli Lilly Stock Declines as Patients Experience Weight Gain Following Discontinuation of Zepbound

Eli Lilly Stock Declines as Patients Experience Weight Gain Following Discontinuation of Zepbound

December 12, 2023

Eli Lilly Secures Second FDA Approval for Jaypirca in Lymphoma Treatment

Eli Lilly Secures Second FDA Approval for Jaypirca in Lymphoma Treatment

December 4, 2023